Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

HHS diverts $40M to immigration crisis under Trump policy

President Donald Trump’s policy of “zero tolerance” on illegal immigration has led HHS to redirect millions in funding to house migrant children separated from their parents at the border.

Thumbnail

HHS proposals for 340B drug pricing program prompt industry objections

Proposed changes to the 340B drug pricing program, in addition to other cuts in payments, are being called out by industry associations and providers.

Thumbnail

'Breakthrough' drug designations result in less certainty

Speeding up the regulatory process has led to uncertainty about the effectiveness of some new drugs.

Thumbnail

Humana exec tapped for Walmart’s health, wellness division

Sean Slovenski, a former executive at Humana, has been hired to run Walmart’s healthcare business, Bloomberg reported.

Trainer Rx selects healthcare veteran Mark Olson as its CEO

Trainer Rx Selects Healthcare Veteran Mark Olson as its CEO

Hospital utilization slows as healthcare moves to cheaper care settings

Hospital utilization is slowing down in its growth, according to a recent survey of hospital administrators. The trend underscores the shift across the healthcare system away from high-cost settings toward lower-cost outpatient utilization.

Thumbnail

Foxconn, Aurora Advocate to collect data from 13K employees to streamline care delivery

Foxconn made headlines when it announced plans to build a $10 billion plant in Racine County, Wisconsin. Now, the Taiwanese tech giant has sights set on improving healthcare for the 13,000 employees who will work at the facility.

Thumbnail

HHS officials resign after Twitter controversies

Inflammatory tweets have led to the departures of two HHS political appointees who worked on President Donald Trump’s campaign.

Displaying 3369 - 3376 of 6655

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup